VAQTA® (Hepatitis A Vaccine, Inactivated) is indicated for the prevention of disease caused by hepatitis A virus (HAV) in persons 12 months of age and older. The primary dose should be given at least 2 weeks prior to expected exposure to HAV.

VAQTA® é indicada para a prevenção da infecção causada pelo vírus da hepatite A. Recomenda-se a vacinação de crianças acima de 12 meses de idade, adolescentes e adultos que corram risco de contrair, de disseminar a doença ou …

Hepatitis A (HepA) vaccines are prepared from formalin-inactivated, cell culture–derived hepatitis A virus. Both vaccines are available in pediatric and adult formulations. A combined hepatitis A vaccine/hepatitis B vaccine is also available.

VAQTA® (Hepatitis A Vaccine, Inactivated) is indicated for the prevention of disease caused by hepatitis A virus (HAV) in persons 12 months of age and older. The primary dose should be given at least 2 weeks prior to expected exposure to HAV. Dosage and Administration for VAQTA.

根据制造商的不同，成年人在0和6至12个月（Havrix）或0和6到18个月（Vaqta）时接种两剂系列疫苗。 或者成人可与甲肝和乙肝疫苗联合起来给三次疫苗接种的方案：在0、1和6个月分别接种。

VAQTA® (Hepatitis A Vaccine, Inactivated) is indicated for the prevention of disease caused by hepatitis A virus (HAV) in persons 12 months of age and older. The primary dose should be given at least 2 weeks prior to expected exposure to HAV.

VAQTA® ist ein Totimpfstoff zur Prävention von Hepatitis A. Im Kühlschrank lagern (2 °C – 8 °C). Nicht einfrieren! Einfrieren zerstört die Wirksamkeit des Impfstoffs. Informationen zu VAQTA®. Haben Sie Fragen zur Verfügbarkeit unserer Produkte?

• VAQTA is a vaccine that helps prevent Hepatitis A. Hepatitis A is an infection of the liver. • It is a vaccine for people 12 months of age and older. What do you need to know about VAQTA? •...

2020年10月26日 · Tradename: VAQTA Manufacturer: Merck Sharp & Dohme Corp. Indications: For the prevention of disease cause by hepatitis A virus (HAV) in persons 12 months of age and older. Product Information

Depending on the manufacturer, adults are given the vaccine in a 2-dose series at 0 and 6 to 12 months (Havrix) or 0 and 6 to 18 months (Vaqta). Or adults may be given the combination HepA and HepB vaccine on a 3-dose schedule: at 0, 1, and 6 months.